Tarsus Pharmaceuticals Reports Q3 Revenue of $194.6M
Tarsus Pharmaceuticals reported Q3 revenue of $194.6 million, versus a FactSet estimate of $187.8 million.
Related stories
Alupar Chile Subsidiary Wins US$85 Million Transmission Project
Alupar Inversiones Chile won a US$85 million power transmission project.
M impact | EQUITY | Nov 04, 2026, 12:56 AM UTC
Azevedo & Travassos Energia Approves a Capital Increase
M impact | EQUITY | Nov 04, 2026, 12:56 AM UTC
European Futures Fall: Euro Stoxx 50 Down 0.9%, DAX Down 0.86%
M impact | EQUITY | Nov 04, 2026, 12:54 AM UTC
Mitsui Chemicals Shares Fall 10.12%
M impact | EQUITY | Nov 04, 2026, 12:51 AM UTC
SK Telecom Reports KRW411.80B Third-Quarter Net Profit
SK Telecom reported third-quarter net profit of KRW411.80 billion, versus a loss of KRW166.70 billion.
M impact | EQUITY | Nov 04, 2026, 12:49 AM UTC
SK Telecom Reports Third-Quarter Operating Profit of KRW552.30B
SK Telecom reported third-quarter operating profit of KRW552.30B, compared with KRW48.40B in the comparison period.
M impact | EQUITY | Nov 04, 2026, 12:48 AM UTC